About Accelerate Diagnostics
Accelerate Diagnostics is a company based in Tucson (United States) founded in 1987. The company has 197 employees. Accelerate Diagnostics operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter Tucson, United States
- Employees 197
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website acceleratediagnostics.com
- Social LinkedIn X Facebook
- Annual Revenue$93.85 K (USD)-82as on Dec 31, 2021
- Net Profit-$72.05 K (USD)-415as on Dec 31, 2021
- Latest Funding Round$32M (USD), Post-IPO
Mar 2021
- Employee Count197
Funding Insights of Accelerate Diagnostics
- Total Rounds 9
- Last Round Post-IPO — $32M
- First Round $275,000
(Mar 2010)
All 9 funding rounds of Accelerate Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $32M | Post-IPO | – | – | – |
| Aug 2019 | $999,992 | Post-IPO | – | – | – |
| Mar 2018 | $171.5M | Post-IPO | – | – | – |
| May 2017 | $79.3M | Post-IPO | – | – | – |
| Jun 2014 | $19.5M | Post-IPO | – | – | – |
| May 2014 | $45M | Post-IPO | – | – | – |
| Aug 2013 | $3.32M | Post-IPO | – | – | – |
| Jun 2012 | $14.42M | Post-IPO | – | – | – |
| Mar 2010 | $275,000 | Post-IPO | – | – | – |
Timeline of Accelerate Diagnostics
4 dated milestones of Accelerate Diagnostics across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Accelerate Diagnostics is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $275K.
- Funding Latest funding round, Post-IPO, of $32.0M.
Competitors of Accelerate Diagnostics
Accelerate Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| clearlabs.com | 2014 | Menlo Park, United States | $171.09M | 55 | Food safety technologies are provided for pathogen identification. | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| availsmedical.com | 2013 | Menlo Park, United States | $8.66M | – | Point-of-care devices are developed for infection diagnosis and treatment optimization. | |
| seegene.com | 2000 | Seoul, South Korea | – | – | Developer of molecular diagnostic kits to detect infectious and genetic diseases | |
| curetis.com | 2007 | Holzgerlingen, Germany | $127.14M | 55 | Molecular diagnostics platform is provided for infectious disease detection. | |
| nowdx.com | 2013 | Bentonville, United States | $65.69M | 28 | Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases |
Detailed competitors of Accelerate Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Accelerate Diagnostics
The website of Accelerate Diagnostics (acceleratediagnostics.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 14.5% vs previous month
Websites whose visitors overlap most with Accelerate Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medicaldevice-network.com | 100% | – | #456,669 | View details | |
| biodesix.com | 93% | 7.4K | #2,413,737 | View details | |
| accuray.com | 75% | 22K | #1,313,331 | View details | |
| astekdx.com | 30% | 1.8K | #7,622,895 | View details |
Latest news on Accelerate Diagnostics
Complete news archive for Accelerate Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Accelerate Diagnostics
10 companies that operate in the same segment as Accelerate Diagnostics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Accelerate Diagnostics
Accelerate Diagnostics was founded in 1987 and raised its 1st funding round 23 years after it was founded.
Accelerate Diagnostics is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
Accelerate Diagnostics has 197 employees.
Annual revenue of Accelerate Diagnostics is $93.85K as on Dec 31, 2021.
Accelerate Diagnostics was founded in 1987 in Tucson, United States, within the medical diagnostics sector. In vitro solutions for identifying and testing antibiotic susceptibility of infectious pathogens are developed. The BACcel platform is utilized, featuring a culture-free process that incorporates genomic and phenotypic technologies to reduce time to results. Operations focus on instrumentation for healthcare applications in infection control.
Accelerate Diagnostics's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.